WallStreetZen

NYSE: NVS
Novartis Ag Earnings & Revenue

NVS past earnings growth

How has NVS's earnings growth performed historically?
Company
-5.88%
Industry
13.35%
Market
37.62%
NVS's earnings have grown slower (3.99% per year) than the US Drug Manufacturers - General industry average (4.06%)
Performance
NVS's earnings have grown slower (3.99% per year) than the US market average (19.73%)
Performance
NVS's earnings growth is slowing down - its growth over the last year (-5.88%) is below its 5-year compound annual rate (3.99%)
Performance

NVS past revenue growth

How has NVS's revenue growth performed historically?
Company
5.59%
Industry
12.11%
Market
20.3%
NVS's revenue has grown slower (-1.92% per year) than the US Drug Manufacturers - General industry average (5.94%)
Performance
NVS's revenue has grown slower (-1.92% per year) than the US market average (18.37%)
Performance
NVS's revenue growth is accelerating - its growth over the last year (5.59%) is above its 5-year compound annual rate (-1.92%)
Performance

NVS earnings and revenue history

Current Revenue
$48.7B
Current Earnings
$11.7B
Current Profit Margin
24.1%
NVS's has not demonstrated consistent long-term earnings growth over the past 10 years (38.38%)
Performance

NVS Return on equity

Current Company
17.5%
Current Industry
36.3%
Current Market
15.1%
NVS's Return on Equity (17.5%) shows a company that is not efficient at transforming shareholder equity into returns
Performance

NVS Return on assets

Current Company
8.9%
Current Industry
9.4%
Current Market
6.8%
NVS is generating higher Return on Assets (8.9%) than the US Drug Manufacturers - General industry average (7.12%)
Performance

NVS Return on capital employed

Current Company
15.95%
Current Industry
14.3%
NVS has gotten more efficient at generating Return on Capital (15.95%) compared to 3 years ago (7.91%)
Performance

Novartis Ag Earnings & Revenue FAQ

What was NVS's earnings growth in the past year?

As of Q2 2021, Novartis Ag's earnings has grown -5.88% year over year. This is 19.24 percentage points lower than the US Drug Manufacturers - General industry earnings growth rate of 13.35%. Novartis Ag's earnings in the past year totalled $11.73 billion.

What was NVS's revenue growth in the past year?

As of Q2 2021, Novartis Ag's revenue has grown 5.59% year over year. This is 6.51 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 12.11%. Novartis Ag's revenue in the past year totalled $48.68 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.